We are live on ! Find out more
AG

Algert Global Portfolio holdings

AUM $6.65B
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+13.2%
1 Year Est. Return
+53.68%
3 Year Est. Return
+140.8%
5 Year Est. Return
+204.57%
10 Year Est. Return
+1,528.09%
AUM
$4.77B
AUM Growth
+$731M
Cap. Flow
+$361M
Cap. Flow %
7.56%
Top 10 Hldgs %
5.9%
Holding
1,379
New
219
Increased
460
Reduced
380
Closed
212

Top Sells

Rank Stock Value
1
GMED icon
Globus Medical
GMED
+$11.3M
2
HURN icon
Huron Consulting
HURN
+$10.8M
3
FHI icon
Federated Hermes
FHI
+$10.5M
4
OUT icon
Outfront Media
OUT
+$10.4M
5
GFF icon
Griffon
GFF
+$10.3M

Sector Composition

Rank Sector Weight
1 Technology 16.45%
2 Industrials 15.7%
3 Financials 15.48%
4 Consumer Discretionary 12.41%
5 Healthcare 12.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WGS icon
401
GeneDx Holdings
WGS
$1.86B
$4.02M 0.08%
43,580
-4,146
-9% -$325K
GAP
402
The Gap Inc
GAP
$7.07B
$4.02M 0.08%
184,399
-292,936
-61% -$6.55M
KMPR icon
403
Kemper
KMPR
$1.62B
$4.02M 0.08%
62,234
+45,584
+274% +$2.82M
KALU icon
404
Kaiser Aluminum
KALU
$2.69B
$3.99M 0.08%
49,940
+8,247
+20% +$561K
HWC icon
405
Hancock Whitney
HWC
$6.2B
$3.98M 0.08%
69,395
-30,050
-30% -$1.6M
EA icon
406
Electronic Arts
EA
$52.4B
$3.97M 0.08%
24,887
+18,727
+304% +$2.77M
ENPH icon
407
Enphase Energy
ENPH
$5.22B
$3.97M 0.08%
100,160
+51,990
+108% +$2.4M
AHR icon
408
American Healthcare REIT
AHR
$11B
$3.96M 0.08%
107,822
-15,202
-12% -$505K
PEGA icon
409
Pegasystems
PEGA
$4.34B
$3.94M 0.08%
+72,716
New +$3.29M
AXSM icon
410
Axsome Therapeutics
AXSM
$12.3B
$3.91M 0.08%
37,430
+11,490
+44% +$1.22M
MC icon
411
Moelis & Co
MC
$4.9B
$3.91M 0.08%
62,690
-1,250
-2% -$70.2K
CATY icon
412
Cathay General Bancorp
CATY
$4.11B
$3.9M 0.08%
85,606
+8,440
+11% +$359K
GME icon
413
GameStop
GME
$9.69B
$3.9M 0.08%
159,811
+31,060
+24% +$833K
MGY icon
414
Magnolia Oil & Gas
MGY
$4.73B
$3.9M 0.08%
173,334
+112,014
+183% +$2.48M
ABM icon
415
ABM Industries
ABM
$2.75B
$3.88M 0.08%
82,210
-28,687
-26% -$1.39M
LXP icon
416
LXP Industrial Trust
LXP
$3.6B
$3.86M 0.08%
93,399
-8,704
-9% -$358K
GILD icon
417
Gilead Sciences
GILD
$162B
$3.83M 0.08%
34,529
+312
+0.9% +$33.2K
SIBN icon
418
SI-BONE Inc
SIBN
$741M
$3.82M 0.08%
+203,019
New +$3.37M
ARE icon
419
Alexandria Real Estate Equities
ARE
$8.65B
$3.81M 0.08%
+52,410
New +$3.89M
RGLD icon
420
Royal Gold
RGLD
$17.1B
$3.81M 0.08%
21,404
-5,370
-20% -$951K
RYTM icon
421
Rhythm Pharmaceuticals
RYTM
$7.13B
$3.81M 0.08%
60,219
-1,242
-2% -$76K
UDMY
422
DELISTED
Udemy
UDMY
$3.8M 0.08%
540,534
+99,430
+23% +$686K
CSTL icon
423
Castle Biosciences
CSTL
$752M
$3.78M 0.08%
185,181
+40,870
+28% +$757K
QRVO icon
424
Qorvo
QRVO
$7.89B
$3.77M 0.08%
44,360
+34,680
+358% +$2.5M
IESC icon
425
IES Holdings
IESC
$13.4B
$3.76M 0.08%
12,694
+2,870
+29% +$676K

Similar funds

Algert Global's Q2 2025 Portfolio in Review

As of Q2 2025, Algert Global held 1,379 positions worth $4.77B, up 18% from $4.04B the previous quarter. Its ten largest holdings account for 5.9% of the portfolio.

Algert Global deployed $361M of net new capital in Q2 2025, opening 219 new positions and adding to 460 existing holdings. Its largest new stake was Millrose Properties Inc: 553,296 shares worth $15.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Huron Consulting, an estimated $10.8M trimmed.

  • Algert Global's largest Q2 2025 buy was Millrose Properties Inc: 553,296 shares worth $15.8M.
  • Algert Global added most to Albemarle in Q2 2025, an estimated $16.7M increase.
  • Algert Global's biggest Q2 2025 reduction was Huron Consulting, cutting an estimated $10.8M.
  • Algert Global fully exited Globus Medical in Q2 2025, selling an estimated $11.3M.
  • Algert Global's ten largest holdings make up 5.9% of its $4.77B portfolio in Q2 2025.
  • Algert Global opened 219 new positions and closed 212 in Q2 2025.
  • Algert Global's portfolio value rose 18% quarter-over-quarter to $4.77B.

Based on Algert Global's 13F filing for Q2 2025, filed 14 Aug 2025.